Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATP Infusions in Palliative Home Care
NCT00565188Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2002
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of adenosine 5'-triphosphate in cancer (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Survival at 8 weeks, Physical restriction at 8 weeks and 2 more. Started Mar 2002; status: completed.
02
Drugs
adenosine 5'-triphosphate
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00565188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565188.